Literature DB >> 17091325

Retrograde approach for device closure of muscular ventricular septal defects in children and adolescents, using the Amplatzer muscular ventricular septal defect occluder.

Al-Ata Jameel1, Amin Muhammed Arfi, Hussain Arif, Kouatli Amjad, Galal Mohammed Omar.   

Abstract

This study presents technique and initial experience of retrograde deployment of the Amplatzer muscular ventricular septal defect occluder (AmVSDo) for closure of muscular ventricular septal defects (VSDs). The conventional technique for closing muscular VSDs involves the creation of an arteriovenous guidewire circuit and use of a transvenous approach for device deployment. Seven patients aged 2.2-15 years underwent transcatheter closure of a muscular VSD using the retrograde approach without making the arteriovenous wire circuit. Mean fluoroscopy and procedural times were compared to those previously reported in publications describing the use of the antegrade approach. Unpaired Student's t-test was used to compare the two parameters in two groups. Our technique was successful in all patients reported. The mean fluoroscopy time in the retrograde versus the antegrade group was 33.8 +/- 20.9 and 41.9 +/- 6.2 minutes, respectively (not significant), and the mean procedural time in the two groups was 91.1 +/- 22.1 and 114 +/- 33.9 minutes respectively (p = 0.025). No complications were noted. We suggest that some muscular VSDs can be safely closed retrogradely without the use of an arteriovenous loop, thus reducing the radiation exposure and also the cost of the procedure. Further studies are needed to confirm this initial experience.

Entities:  

Mesh:

Year:  2006        PMID: 17091325     DOI: 10.1007/s00246-006-1365-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  23 in total

1.  Transcatheter closure of apical ventricular muscular septal defect combined with arterial switch operation in a newborn infant.

Authors:  J Rodés; J F Piéchaud; R Ouaknine; S Hulin; L Cohen; S Magnier; Y Lecompte; T Lefèvre
Journal:  Catheter Cardiovasc Interv       Date:  2000-02       Impact factor: 2.692

2.  Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations.

Authors:  Z M Hijazi; F Hakim; F Al-Fadley; J Abdelhamid; Q L Cao
Journal:  Catheter Cardiovasc Interv       Date:  2000-02       Impact factor: 2.692

3.  Transcatheter closure of multiple muscular ventricular septal defects using Gianturco coils.

Authors:  H A Latiff; M Alwi; G Kandhavel; H Samion; R Zambahari
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

4.  Description of ventricular septal defects--or how long is a piece of string?

Authors:  R H Anderson; A E Becker; M Tynan
Journal:  Int J Cardiol       Date:  1986-12       Impact factor: 4.164

5.  Perforation of the right aortic valve cusp: complication of ventricular septal defect closure with a modified Rashkind umbrella.

Authors:  M Vogel; M L Rigby; D Shore
Journal:  Pediatr Cardiol       Date:  1996 Nov-Dec       Impact factor: 1.655

6.  Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children.

Authors:  B D Thanopoulos; G S Tsaousis; G N Konstadopoulou; A G Zarayelyan
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

7.  Transcatheter closure of congenital muscular ventricular septal defect.

Authors:  Ramesh Arora; Vijay Trehan; Ashish K Thakur; Vimal Mehta; P P Sengupta; M Nigam
Journal:  J Interv Cardiol       Date:  2004-04       Impact factor: 2.279

8.  Primary transcatheter umbrella closure of perimembranous ventricular septal defect.

Authors:  M L Rigby; A N Redington
Journal:  Br Heart J       Date:  1994-10

9.  Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.

Authors:  Ralf Holzer; David Balzer; Qi-Ling Cao; Ken Lock; Ziyad M Hijazi
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094

10.  Muscular ventricular septal defects repaired with left ventriculotomy.

Authors:  S P Griffiths; G K Turi; K Ellis; E Krongrad; L H Swift; W M Gersony; F O Bowman; J R Malm
Journal:  Am J Cardiol       Date:  1981-11       Impact factor: 2.778

View more
  4 in total

1.  Antegrade percutaneous closure of membranous ventricular septal defect using X-ray fused with magnetic resonance imaging.

Authors:  Kanishka Ratnayaka; Venkatesh K Raman; Anthony Z Faranesh; Merdim Sonmez; June-Hong Kim; Luis F Gutiérrez; Cengizhan Ozturk; Elliot R McVeigh; Michael C Slack; Robert J Lederman
Journal:  JACC Cardiovasc Interv       Date:  2009-03       Impact factor: 11.195

2.  Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach.

Authors:  Nihat Pekel; Ertuğrul Ercan; Mehmet Emre Özpelit; Ferhat Özyurtlu; Akar Yılmaz; Caner Topaloğlu; Serkan Saygı; Serkan Yakan; İstemihan Tengiz
Journal:  Anatol J Cardiol       Date:  2017-02-21       Impact factor: 1.596

3.  Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach.

Authors:  Sedigheh Saedi; Tahereh Saedi
Journal:  Anatol J Cardiol       Date:  2017-05-09       Impact factor: 1.596

Review 4.  Interventional Cardiology for Congenital Heart Disease.

Authors:  Damien Kenny
Journal:  Korean Circ J       Date:  2018-03-29       Impact factor: 3.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.